Portfolio

If wirehouses decided to adopt a salary-plus-bonus compensation model, how would they do it?

The nation's largest IBDs are growing again, but are they innovating fast enough to keep up with the industry's transformation?

This interactive tool provides the full collection of data from Financial Planning's 33rd annual study of the largest firms in the space.

Thirteen of the top 25 companies generated double-digit growth in 2017 as rivals close in on the perennial No. 1 firm.

The gap for brand-name prescription drugs for Medicare beneficiaries is likely to narrow down to 25% of drug costs from the scheduled 30% next year.

Wells Fargo’s advisor headcount continues to fall in the second quarter.

These portfolios look poised to shrug off their recent underperformance.

Rates rising and falling? This strategy works either way.

Craig Schmell says the firm terminated him because of alcohol and drug addiction issues he had 30 years ago.

The declines, he says, were the result of a widening gap between U.S. and German bond yields triggered by the crisis in the eurozone.